Medical Response to Radiation Exposure: the Role of Hematologists |
03/17/2025 - 4:00pm to 5:00pm EDT |
HEMATOLOGIC MALIGNANCIES GRAND ROUNDS 2025 |
03/24/2025 - 4:00pm to 5:00pm EDT |
Toward a Cellular Therapy Cure for Autoimmune Diseases |
03/31/2025 - 4:00pm to 5:00pm EDT |
HEMATOLOGIC MALIGNANCIES GRAND ROUNDS 2025 |
04/07/2025 - 4:00pm to 5:00pm EDT |
A Case-Based Review on Venous Thromboembolic Events in Malignant Hematology |
04/14/2025 - 4:00pm to 5:00pm EDT |
Just how favorable is favorable-risk AML? AML with NPM1 mutation and the Emergence of the Menin Inhibitors |
04/21/2025 - 4:00pm to 5:00pm EDT |
ASCT or CAR T as Consolidation in Newly Diagnosed Multiple Myeloma |
04/28/2025 - 4:00pm to 5:00pm EDT |
HEMATOLOGIC MALIGNANCIES GRAND ROUNDS 2025 |
05/05/2025 - 4:00pm to 5:00pm EDT |
Smoldering Multiple Myeloma: Risk Stratification and Management |
05/12/2025 - 4:00pm to 5:00pm EDT |
HEMATOLOGIC MALIGNANCIES GRAND ROUNDS 2025 |
05/19/2025 - 4:00pm to 5:00pm EDT |